Novavax Inc. said Thursday it has agreed to start shipping doses of its COVID-19 vaccine candidate to the COVAX program in the third quarter of 2021 in an effort to deliver on its promise to provide 1.1 billion shots to the global vaccination program.
Novavax said it will manufacture and ship 350 million shots itself. India’s Serum Institute (SII) will provide the remainder of the 1.1 billion shots to COVAX through a separate agreement.
The COVAX facility is a global initiative aimed at access to COVID-19 vaccines for poorer countries. It is co-led by GAVI, the World Health Organization (WHO), and the Coalition for Epidemic Preparedness Innovations.
GAVI’s chief executive, S…
Keep on reading: Novavax to start shipping COVID-19 vaccines to COVAX program in Q3